Clinical Trials for Mesothelioma Patients: Valproate and Doxorubicin Patient Inclusion Criteria

Read about the patient inclusion criteria for a current clinical trial being conducted to study Valproate and Doxorubicin in patients who have been diagnosed with mesothelioma. At this time, the study is only being conducted in Belgium and France. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Inclusion Criteria
Histological diagnosis of malignant mesothelioma

Unresectable or inoperable malignant mesothelioma failing after at least one prior chemotherapy regimen including platinum derivatives (cisplatin or carboplatin)

At least one evaluable or measurable CT-lesion

Availability for participating in the detailed follow-up of the protocol

Signed informed consent

If you or a loved one has been doagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.